PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000975144.60985.f9 |
| _version_ | 1797279879455047680 |
|---|---|
| author | Cesar Rodriguez Valdes Katja Weisel Rachid Baz Akshanth Polepally Jeremy A. Ross Ziyi Jin Kristin D’amico Orlando F. Bueno Leanne Lash Fleming Peter Voorhees |
| author_facet | Cesar Rodriguez Valdes Katja Weisel Rachid Baz Akshanth Polepally Jeremy A. Ross Ziyi Jin Kristin D’amico Orlando F. Bueno Leanne Lash Fleming Peter Voorhees |
| author_sort | Cesar Rodriguez Valdes |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:32:20Z |
| format | Article |
| id | doaj.art-3928bd6ae4434486bf6eaef2cf4593fb |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:32:20Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-3928bd6ae4434486bf6eaef2cf4593fb2024-03-03T10:07:37ZengWileyHemaSphere2572-92412023-08-017e60985f910.1097/01.HS9.0000975144.60985.f9202308003-01960PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSIONCesar Rodriguez Valdes0Katja Weisel1Rachid Baz2Akshanth Polepally3Jeremy A. Ross4Ziyi Jin5Kristin D’amico6Orlando F. Bueno7Leanne Lash Fleming8Peter Voorhees91 Icahn School of Medicine at Mount Sinai, Medical Oncology and Hematology, New York, NY, United States2 Department of oncology, Hematology, and Bone Marrow Transplantation with Section of pneumology, University Medical Center Hamburg-Eppendorf3 Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States4 AbbVie Inc, South San Francisco, IL, United States5 AbbVie Inc, North Chicago, IL, United States6 AbbVie Inc, North Chicago, IL, United States6 AbbVie Inc, North Chicago, IL, United States6 AbbVie Inc, North Chicago, IL, United States6 AbbVie Inc, North Chicago, IL, United States7 Levine Cancer Institute, Atrium Health/ Wake Forest Baptist, Charlotte, North Carolina, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000975144.60985.f9 |
| spellingShingle | Cesar Rodriguez Valdes Katja Weisel Rachid Baz Akshanth Polepally Jeremy A. Ross Ziyi Jin Kristin D’amico Orlando F. Bueno Leanne Lash Fleming Peter Voorhees PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION HemaSphere |
| title | PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION |
| title_full | PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION |
| title_fullStr | PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION |
| title_full_unstemmed | PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION |
| title_short | PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION |
| title_sort | pb2088 abbv 383 in combination with anti cancer regimens in relapsed or refractory multiple myeloma dose escalation and expansion |
| url | http://journals.lww.com/10.1097/01.HS9.0000975144.60985.f9 |
| work_keys_str_mv | AT cesarrodriguezvaldes pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT katjaweisel pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT rachidbaz pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT akshanthpolepally pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT jeremyaross pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT ziyijin pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT kristindamico pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT orlandofbueno pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT leannelashfleming pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion AT petervoorhees pb2088abbv383incombinationwithanticancerregimensinrelapsedorrefractorymultiplemyelomadoseescalationandexpansion |